In part 1 of this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the reasoning behind changes to cholesterol goals.
Read More »Daily Archives: Apr 6, 2018
Yehuda Handelsman Part 2, Prescribing SGLT 2 Inhibitors
In part 2 of this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the actual cost to the lives of patients who are put on more expensive, but life-saving, diabetes drugs.
Read More »Yehuda Handelsman Part 3, Managing LDL of Patients
In part 3 of this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about his LDL recommendations according to the patient and varying health events.
Read More »Yehuda Handelsman Part 4, Safe A1C Levels for Diabetes Patients
In part 4 of this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about safely lowering patient A1c to their particular goal without hypoglycemia.
Read More »Yehuda Handelsman Part 5, CGM and the Future of Diabetes
In part 5 of this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the more exciting diabetes technology developments.
Read More »Yehuda Handelsman Part 6, FDA Approving New Drugs
In part 6, the conclusion of this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the ultimate good that came from the failure of Avandia.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.